Intelligent Bleeding Control Systems via Coordinated Trigeminal and Vagal Nerve Stimulation

A novel system integrating coordinated trigeminal and vagal nerve stimulation with advanced technologies like AI, IoT, and blockchain to create a more effective, personalized, and secure bleeding control solution.

The original patent, 'Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation', provides a foundational approach to preventing and treating bleeding. However, it lacks the ability to adapt to individual patient needs, ensure data security, and provide real-time feedback. The new inventive concept addresses these limitations by incorporating synergistic technologies to create a more powerful system.

The intelligent bleeding control system comprises a wearable device with at least two electrodes for non-invasive electrical stimulation of the trigeminal and vagal nerves. A machine learning module predicts optimal stimulation parameters based on real-time patient data and adjusts the stimulation accordingly. The system also includes an IoT-enabled sensor module that monitors vital signs and adjusts the stimulation in real-time. Furthermore, a blockchain-based decentralized data storage module ensures secure and transparent storage of patient data and stimulation protocols. The system can transmit stimulation data to a cloud-based server for analysis and feedback, enabling personalized treatment plans.

The new claims introduce the innovative integration of AI, IoT, and blockchain technologies with coordinated trigeminal and vagal nerve stimulation, providing a novel and non-obvious solution for bleeding control. The incorporation of machine learning, IoT-enabled sensors, and blockchain-based data storage creates a more effective, adaptive, and secure system that goes beyond the original patent's capabilities.

Alternative embodiments of the inventive concept could include the use of different AI algorithms, various IoT-enabled sensors, or alternative blockchain protocols. Additionally, the system could be adapted for use in different medical settings, such as emergency response or surgical procedures.

The intelligent bleeding control system has significant commercial potential in the medical device industry, particularly in the areas of emergency medicine, surgery, and wound care. The system's ability to provide personalized, real-time bleeding control solutions could revolutionize the treatment of bleeding disorders and traumatic injuries, addressing a significant unmet medical need.